chronic hepatitis B (CHB)
Conditions
Interventions
case series:None
Sponsors
Zhenjiang Third People's Hospital
Eligibility
Sex/Gender
All
Age
12 Years to 98 Years
Inclusion criteria
Inclusion criteria: 1. Past patients who meet the CHB diagnostic criteria of ''Guidelines for the Prevention and Treatment of Chronic Hepatitis B (2019 Edition)'' and have a history of taking TAF antiviral drugs (From November 2018 to November 2021, outpatient/inpatient patients who were diagnosed with chronic hepatitis B in our hospital and who took TAF drugs were selected as the research subjects, and their clinical data were retrospectively analyzed); and patients who meet the requirements and agree to be included in this study; 2. The clinical data are relatively complete, and the course of treatment is at least 48 weeks.
Exclusion criteria
Exclusion criteria: 1. No follow-up records; 2. Patients who were lost to follow-up or dropped out before the observation end point.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Deoxyribonucleic acid determination of hepatitis B virus;Alanine aminotransferase;HBsAg;HBeAg;Renal function;Determination of inorganic phosphorus and calcium;Blood Lipid determination; | — |
Countries
China
Contacts
Public ContactTan Youwen
Zhenjiang Third People's Hospital
Outcome results
None listed